Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$21.23 -0.15 (-0.70%)
At close: Nov 16, 2026 · 4:00 PM EST

Amneal Pharmaceuticals (AMRX) Income After Tax (2017 - 2026)

Updated

Amneal Pharmaceuticals' Income After Tax was $12.31 million in Q3 2026, down 32.1% from $18.13 million a year earlier and down 82.3% from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) Income After Tax (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, Amneal Pharmaceuticals' Income After Tax was $209.49 million through Sep 30, 2026, up 263.6% year-over-year; for FY2025, it was $127.93 million.

  • Income After Tax shows a five-year compound annual growth rate of 13.3% (FY2020 to FY2025).
  • In earlier years, Income After Tax was -$73.88 million in FY2024, -$48.72 million in FY2023, -$254.83 million in FY2022 and $20.17 million in FY2021 (-70.6%).
  • The Q3 2026 figure marks the lowest quarterly Income After Tax since Q4 2024.
  • Compared with a year earlier, Income After Tax was higher in four of the last five quarters, with growth averaging 89.3%.
  • Per Business Quant data, AMRX's Income After Tax in the three quarters before Q3 2026 was $69.61 million (Q2 2026), $78 million (Q1 2026) and $49.57 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income After Tax (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 210.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 4.22 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 4.80 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 2.43 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 3.25 Bn
10 Amneal Pharmaceuticals 7.10 Bn 6.33 Bn 334.12 Mn 12.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 12.31 Mn
Jun 30, 2026 69.61 Mn
Mar 31, 2026 78.00 Mn
Dec 31, 2025 49.57 Mn
Sep 30, 2025 18.13 Mn
Jun 30, 2025 35.61 Mn
Mar 31, 2025 24.62 Mn
Dec 31, 2024 -20.74 Mn
Sep 30, 2024 11.76 Mn
Jun 30, 2024 16.79 Mn
Mar 31, 2024 -81.68 Mn
Dec 31, 2023 -93.34 Mn
Sep 30, 2023 25.06 Mn
Jun 30, 2023 29.68 Mn
Mar 31, 2023 -10.13 Mn
Dec 31, 2022 -5.86 Mn
Sep 30, 2022 -2.42 Mn
Jun 30, 2022 -240.13 Mn
Mar 31, 2022 -6.42 Mn
Dec 31, 2021 -20.42 Mn
API Access

Amneal Pharmaceuticals Income After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=AMRX&period=max&api_key=YOUR_API_KEY